Toll Free: 1-888-928-9744

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2016 Update

Published: Jun 22, 2016 | Pages: 33 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Immunodiagnostic Systems Holdings plc (IDS) is a diagnostic solution provider that designs, develops, and supplies immunoassays and automated immunoanalyser technologies. The company researches on bone turnover market, cartilage market, and animal research. Its clinical areas include bone metabolism, calcium metabolism, CKD-MBD (chronic kidney disease and mineral bone disorders), fertility, growth disorders, and hypertension. IDS' services include application training and advice, customized training, qualified customer care centers and regionalized proximity teams. The company's specification includes carousel, cuvette loader, ancillary reagents, waste collection, graphic user interface, operating system, and dimensions, among others. It has presence in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Immunodiagnostic Systems Holdings plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Immunodiagnostic Systems Holdings plc Company Snapshot 6 Immunodiagnostic Systems Holdings plc Company Overview 6 Immunodiagnostic Systems Holdings plc Pipeline Products and Clinical Trials Overview 7 Immunodiagnostic Systems Holdings plc - Pipeline Analysis Overview 10 Key Facts 10 Immunodiagnostic Systems Holdings plc - Major Products and Services 11 Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage 12 Immunodiagnostic Systems Holdings plc Pipeline Products Overview 14 IDS-iSYS - ACTH Assay 14 IDS-iSYS - ACTH Assay Product Overview 14 IDS-iSYS - InaKtif MGP Assay 15 IDS-iSYS - InaKtif MGP Assay Product Overview 15 IDS-iSYS - Intact PINP Assay 16 IDS-iSYS - Intact PINP Assay Product Overview 16 IDS-iSYS - Total Testosterone Assay 17 IDS-iSYS - Total Testosterone Assay Product Overview 17 IDS-iSYS BAP Assay 18 IDS-iSYS BAP Assay Product Overview 18 IDS-iSYS Bioactive PTH (1-84) Kit 19 IDS-iSYS Bioactive PTH (1-84) Kit Product Overview 19 IDS-iSYS Cortisol Assay 20 IDS-iSYS Cortisol Assay Product Overview 20 IDS-iSYS Mark II 21 IDS-iSYS Mark II Product Overview 21 IDS-iSYS MGP Assay 22 IDS-iSYS MGP Assay Product Overview 22 IDS-iSYS Osteocalcin Kit 23 IDS-iSYS Osteocalcin Kit Product Overview 23 IDS-iSYS P1NP Assay 24 IDS-iSYS P1NP Assay Product Overview 24 Immunodiagnostic Systems Holdings plc - Key Competitors 25 Immunodiagnostic Systems Holdings plc - Key Employees 26 Immunodiagnostic Systems Holdings plc - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Recent Developments 29 Immunodiagnostic Systems Holdings plc, Recent Developments 29 Jun 09, 2016: Immunodiagnostic Systems Holdings provides update on re royalty revenues 29 May 06, 2016: Launch of IDS-iSYS 17-OH Progesterone assay - 1st assay in the new IDS fertility portfolio 29 Jun 29, 2015: Immunodiagnostic Systems announces Directorate Change 29 Jun 23, 2015: Immunodiagnostic Systems Holdings announces Final Results 29 Jun 10, 2015: Immunodiagnostic Systems Holdings announces Board Appointment 30 Apr 02, 2015: Immunodiagnostic Systems: Patricio Lacalle Joins as Chief Executive Officer 30 Feb 03, 2015: Patricio Lacalle Appointed As New Chief Executive Officer 31 Dec 24, 2014: Immunodiagnostic Systems Announces Directorate Change 31 Dec 12, 2014: Immunodiagnostic Systems Launch of Fully Automated 1,25-Dihydroxy Vitamin D Assay 31 Dec 04, 2014: Immunodiagnostic Systems Announces Board Change 31 Appendix 33 Methodology 33 About GlobalData 33 Contact Us 33 Disclaimer 33
List of Tables
Immunodiagnostic Systems Holdings plc Pipeline Products and Clinical Trials Overview 7 Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type 7 Immunodiagnostic Systems Holdings plc Pipeline Products by Indication 9 Immunodiagnostic Systems Holdings plc, Key Facts 10 Immunodiagnostic Systems Holdings plc, Major Products and Services 11 Immunodiagnostic Systems Holdings plc Number of Pipeline Products by Development Stage 12 Immunodiagnostic Systems Holdings plc Pipeline Products Summary by Development Stage 13 IDS-iSYS - ACTH Assay - Product Status 14 IDS-iSYS - ACTH Assay - Product Description 14 IDS-iSYS - InaKtif MGP Assay - Product Status 15 IDS-iSYS - InaKtif MGP Assay - Product Description 15 IDS-iSYS - Intact PINP Assay - Product Status 16 IDS-iSYS - Intact PINP Assay - Product Description 16 IDS-iSYS - Total Testosterone Assay - Product Status 17 IDS-iSYS - Total Testosterone Assay - Product Description 17 IDS-iSYS BAP Assay - Product Status 18 IDS-iSYS BAP Assay - Product Description 18 IDS-iSYS Bioactive PTH (1-84) Kit - Product Status 19 IDS-iSYS Bioactive PTH (1-84) Kit - Product Description 19 IDS-iSYS Cortisol Assay - Product Status 20 IDS-iSYS Cortisol Assay - Product Description 20 IDS-iSYS Mark II - Product Status 21 IDS-iSYS Mark II - Product Description 21 IDS-iSYS MGP Assay - Product Status 22 IDS-iSYS MGP Assay - Product Description 22 IDS-iSYS Osteocalcin Kit - Product Status 23 IDS-iSYS Osteocalcin Kit - Product Description 23 IDS-iSYS P1NP Assay - Product Status 24 IDS-iSYS P1NP Assay - Product Description 24 Immunodiagnostic Systems Holdings plc, Key Employees 26 Immunodiagnostic Systems Holdings plc, Other Locations 27 Immunodiagnostic Systems Holdings plc, Subsidiaries 27


List of Figures
Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type 8 Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage 12

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify